Image by re-ality via Flickr
A Richmond, Utah dog struggling for mobility is getting a new leash on life, courtesy of a new stem cell treatment for canines.
It’s not embryonic cells, but the dog’s own that are used in the treatment. North Logan vet Dr. James Israelsen of the Mountain View Veterinary Health Clinic performed the procedure on “Coty.”
Coty with Miller’s wife, Diane Bush.
“We have to harvest some fat from them to isolate the stem cells. And in her case, she’s a thin dog, so we actually harvested a little bit of abdominal fat just from the front of her
Damaged and aged heart tissue of older heart failure External link patients was rejuvenated by stem cells modified by scientists, according to research presented at the American Heart Association’s Basic Cardiovascular Sciences 2012 Scientific Sessions.
The study is simultaneously published in the Journal of the American College of Cardiology.
The research could one day lead to new treatments for heart failure patients, researchers said.
“Since patients with heart failure are normally elderly, their cardiac stem cells aren’t very healthy,” said Sadia Mohsin, Ph.D., one of the study authors and a post-doctoral research scholar at San Diego State University’s Heart Institute
In a study at the University of California, San Diego and VA San Diego Healthcare, researchers were able to regenerate “an astonishing degree” of axonal growth at the site of severe spinal cord injury in rats. Their research revealed that early stage neurons have the ability to survive and extend axons to form new, functional neuronal relays across an injury site in the adult central nervous system (CNS).
The study also proved that at least some types of adult CNS axons can overcome a normally inhibitory growth environment to grow over long distances. Importantly, stem cells across species
Published Research Using Adult Stem Cells for Multiple Sclerosis
A stem cell research study showing that Adult Stem Cells taken from a patient’s fat and then implanted back into that patient, helps improve their Multiple Sclerosis. The research study documented 3 case studies of Multiple Sclerosis patients.
Case Studies of Multiple Sclerosis Patients Implanted with Fat […]
Image via Wikipedia
SAN DIEGO – Novocell, a small, privately held San Diego company, may have found new ways to make money from its technique for coaxing human embryonic stem cells into insulin-producing pancreatic cells.
That’s good news in a field that has had trouble attracting investor funding. Many venture capital firms have been skittish because of politics and the nascency of the embryonic stem cell science.
The biotechnology company announced Tuesday that it received a patent that essentially gives it control over all endoderm cells made from human embryonic stem cells.
Endoderm cells are precursor cells that can eventually develop into cells